Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

Q: What does CUSIP 87978U207 represent in this 13F holders report?

CUSIP 87978U207 is the security identifier for TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2025?

17 institutional investors reported TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 87978U207

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 13,473,733
Total 13F shares: 674,784
Share change: -2,833,041
Total reported value: $4,588,483
Put/Call ratio: 1415%
Price per share: $6.80
Number of holders: 17
Value change: +$1,995,038
Number of buys: 15
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 87978U207?
CUSIP 87978U207 identifies TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 87978U207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Top shareholders of TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Versant Vantage II, L.P.	3/4/5	10%+ Owner	— class O/S missing	2,118,644	$10,127,118	—	29 Apr 2022	3/4/5
Versant Venture Management, LLC	13F	Company	26%	3,507,055	$2,588,207	—	31 Mar 2025	13F
Versant Venture Capital VI, L.P.	3/4/5	10%+ Owner	— class O/S missing	2,328,585	$2,562,608	—	08 Aug 2024	3/4/5
BlackRock, Inc.	13F	Company	3.8%	561,503	$414,389	—	31 Mar 2025	13F
Rock Springs Capital Management LP	3/4/5	10%+ Owner	— class O/S missing	73,654	$352,066	—	30 Dec 2021	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.9%	433,346	$319,827	—	31 Mar 2025	13F
FMR LLC	13F	Company	2.9%	431,932	$318,766	—	31 Mar 2025	13F
UBS Group AG	13F	Company	2.2%	323,699	$238,890	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	2%	297,877	$219,833	—	31 Mar 2025	13F
Stephen R. Brady	3/4/5	President and CEO, Director	— mixed-class rows	596,376 mixed-class rows	$97,853	—	02 Jan 2025	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.77%	114,559	$84,545	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.67%	99,391	$73,351	—	31 Mar 2025	13F
DAVENPORT & Co LLC	13F	Company	0.34%	50,000	$36,900	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.3%	44,465	$32,815	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.28%	41,492	$30,621	—	31 Mar 2025	13F
Samuel Whiting	3/4/5	Chief Medical Officer	— mixed-class rows	279,573 mixed-class rows	$20,390	—	02 Jan 2025	3/4/5
OSAIC HOLDINGS, INC.	13F	Company	0.17%	25,722	$19,018	—	31 Mar 2025	13F
SIMPLEX TRADING, LLC	13F	Company	0.14%	20,422	$15,000	—	31 Mar 2025	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.13%	20,000	$14,660	—	31 Mar 2025	13F
MayTech Global Investments, LLC	13F	Company	0.07%	10,000	$7,380	—	31 Mar 2025	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.03%	3,800	$2,804	—	31 Mar 2025	13F
Millstone Evans Group, LLC	13F	Company	0.01%	800	$590	—	31 Mar 2025	13F
SBI Securities Co., Ltd.	13F	Company	0.01%	767	$566	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	349	$258	—	31 Mar 2025	13F
Parallel Advisors, LLC	13F	Company	0%	236	$174	—	31 Mar 2025	13F
CIBC Private Wealth Group LLC	13F	Company	0%	133	$67	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	0%	77	$57	—	31 Mar 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	48	$35	—	31 Mar 2025	13F
Thomas W. Dubensky	3/4/5	President, Director	— class O/S missing	102,700	—	—	03 Jan 2023	3/4/5
Pierre Lorenzo	3/4/5	Corporate Controller	— class O/S missing	8,477	—	—	21 Jun 2022	3/4/5
Stella Xu	3/4/5	Director	— class O/S missing	6,635	—	—	01 Jul 2021	3/4/5
Thomas Woiwode	3/4/5	Director	— class O/S missing	3,500	—	—	17 Jun 2022	3/4/5

Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q2 2025

As of 30 Jun 2025, Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 674,784 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, UBS Group AG, MORGAN STANLEY, OSAIC HOLDINGS, INC., and NATIONAL BANK OF CANADA /FI/. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.